Connor, Clark & Lunn Investment Management »

Nektar Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $846k 651k 1.30
2024-06-30 $764k 616k 1.24
2024-03-31 $536k 574k 0.93
2023-12-31 $281k 497k 0.57
2023-09-30 $293k 492k 0.60
2023-06-30 $365k 635k 0.58
2023-03-31 $315k 448k 0.70
2022-12-31 $365k 161k 2.26
2022-09-30 $34k 11k 3.17
2022-06-30 $144k 38k 3.81
2022-03-31 $908k 169k 5.39
2021-12-31 $717k 53k 13.50
2021-06-30 $270k 16k 17.16
2019-12-31 $554k 26k 21.58
2014-03-31 $171k 13k 13.36